561
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension

, , , , , , & show all
Pages 427-432 | Received 08 Jan 2012, Accepted 27 Apr 2012, Published online: 18 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andreja Trpkovic, Ivana Resanovic, Julijana Stanimirovic, Djordje Radak, Shaker A. Mousa, Desanka Cenic-Milosevic, Danimir Jevremovic & Esma R. Isenovic. (2015) Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Critical Reviews in Clinical Laboratory Sciences 52:2, pages 70-85.
Read now

Articles from other publishers (23)

Rukhsana Gul, Meshail Okla, Amer Mahmood, Shahid Nawaz, Amina Fallata, Arwa Bazighifan, Musaad Alfayez & Assim A. Alfadda. (2023) Comparison of the Protective Effects of Nebivolol and Metoprolol against LPS-Induced Injury in H9c2 Cardiomyoblasts. Current Issues in Molecular Biology 45:11, pages 9316-9327.
Crossref
Esra Nurlu Temel, Mehtap Savran, Yalcın Erzurumlu, Nursel Hasseyid, Halil Ibrahim Buyukbayram, Gozde Okuyucu, Mehmet Abdulkadir Sevuk, Ozlem Ozmen & Ayse Coskun Beyan. (2023) The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury. Journal of Clinical Medicine 12:5, pages 1721.
Crossref
Yide He, Rongwen Zhu, Yujie Cai, Yiqun Zhang, Yunhai Zhang, Shunlong Pan, Rudolf J. Schneider & Yongjun Zhang. (2022) Transcriptomics and protein biomarkers reveal the detoxifying mechanisms of UV radiation for nebivolol toward zebrafish (Danio rerio) embryos/larvae. Aquatic Toxicology 249, pages 106241.
Crossref
Julia Krzemińska, Magdalena Wronka, Ewelina Młynarska, Beata Franczyk & Jacek Rysz. (2022) Arterial Hypertension—Oxidative Stress and Inflammation. Antioxidants 11:1, pages 172.
Crossref
Vinícius Bocchino Seleme, Gustavo Lenci Marques, Antonio Eduardo Matoso Mendes, Inajara Rotta, Milena Pereira, Emilton Lima Júnior & Claudio L. Pereira da Cunha. (2020) Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis. American Journal of Cardiovascular Drugs 21:2, pages 165-180.
Crossref
K. Uma priya, Ch. Venkataramaiah, N. Y. Sreedhar & C. Naga Raju. (2021) Design, synthesis, characterization and in vitro, in vivo and in silico antimicrobial and antiinflammatory activities of a new series of sulphonamide and carbamate derivatives of a nebivolol intermediate . RSC Advances 11:7, pages 3897-3916.
Crossref
Gisele Facholi Bomfim, Stefany Bruno Assis Cau, Alexandre Santos Bruno, Aline Garcia Fedoce & Fernando S Carneiro. (2018) Hypertension: a new treatment for an old disease? Targeting the immune system. British Journal of Pharmacology 176:12, pages 2028-2048.
Crossref
Annabella Braschi. (2019) Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise. American Journal of Cardiovascular Drugs 19:2, pages 133-171.
Crossref
Thomas J. van 't Erve. (2018) Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α. Redox Biology 17, pages 284-296.
Crossref
Gabriel T. do Vale, Natália A. Gonzaga, Janaina A. Simplicio & Carlos R. Tirapelli. (2017) Nebivolol prevents ethanol-induced reactive oxygen species generation and lipoperoxidation in the rat kidney by regulating NADPH oxidase activation and expression. European Journal of Pharmacology 799, pages 33-40.
Crossref
Mazhar Hussain, Muhammad Saeed, Muhammad Zafar Majeed Babar, Moazzam Ali Atif & Lubna Akhtar. (2017) Nebivolol Attenuates Neutrophil Lymphocyte Ratio: A Marker of Subclinical Inflammation in Hypertensive Patients. International Journal of Hypertension 2017, pages 1-6.
Crossref
Kyle J. DiehlBrian L. StaufferCaitlin A. DowTyler D. BammertDanielle L. BrunjesJared J. GreinerChristopher A. DeSouza. (2016) Chronic Nebivolol Treatment Suppresses Endothelin-1–Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure. Hypertension 67:6, pages 1196-1204.
Crossref
Justin Fongemie & Erika Felix-Getzik. (2015) A Review of Nebivolol Pharmacology and Clinical Evidence. Drugs 75:12, pages 1349-1371.
Crossref
Salim S. Hayek, Joseph C. Poole, Robert Neuman, Alanna A. Morris, Mohamed Khayata, Nino Kavtaradze, Matthew L. Topel, Jose G. Binongo, Qunna Li, Dean P. Jones, Edmund K. Waller & Arshed A. Quyyumi. (2015) Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress. Journal of the American Society of Hypertension 9:3, pages 206-213.
Crossref
Elen Rizzi, Danielle A. Guimaraes, Carla S. Ceron, Cibele M. Prado, Lucas C Pinheiro, Alisson Martins-Oliveira, Raquel F. Gerlach & Jose E. Tanus-Santos. (2014) β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy. Free Radical Biology and Medicine 73, pages 308-317.
Crossref
Ana Paula Cabral de Faria, Vanessa Fontana, Rodrigo Modolo, Natália Ruggeri Barbaro, Andréa Rodrigues Sabbatini, Isabella Fagian Pansani, Silvia E. Ferreira-Melo & Heitor Moreno. (2014) Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension. Clinica Chimica Acta 433, pages 179-183.
Crossref
Augusto C. MontezanoRhian M. Touyz. (2014) Reactive Oxygen Species, Vascular Noxs, and Hypertension: Focus on Translational and Clinical Research. Antioxidants & Redox Signaling 20:1, pages 164-182.
Crossref
Rhian M. Touyz. 2014. Cellular and Molecular Pathobiology of Cardiovascular Disease. Cellular and Molecular Pathobiology of Cardiovascular Disease 257 275 .
Timothy J. Werner, Nabil E. Boutagy, Kristin L. Osterberg, Jose M. Rivero & Kevin P. Davy. (2013) Singular and combined effects of nebivolol and lifestyle modification on large artery stiffness in hypertensive adults. Therapeutic Advances in Cardiovascular Disease 7:6, pages 285-292.
Crossref
Andreas Jekell, Karin Malmqvist, N. Håkan Wallén, David Mörtsell & Thomas Kahan. (2013) Markers of Inflammation, Endothelial Activation, and Arterial Stiffness in Hypertensive Heart Disease and the Effects of Treatment. Journal of Cardiovascular Pharmacology 62:6, pages 559-566.
Crossref
Carla S. Ceron, Elen Rizzi, Danielle A. Guimarães, Alisson Martins-Oliveira, Raquel F. Gerlach & Jose E. Tanus-Santos. (2013) Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension. Free Radical Biology and Medicine 65, pages 47-56.
Crossref
Francesco Fici, Turgay Celik, Sevket Balta, Atila Iyisoy, Murat Unlu, Sait Demitkol, Halil Yaman, Gianmaria Brambilla, Ejder Kardesoglu, Selim Kilic, Mehemet Yokusoglu & Guido Grassi. (2013) Comparative Effects of Nebivolol and Metoprolol on Red Cell Distribution Width and Neutrophil/Lymphocyte Ratio in Patients With Newly Diagnosed Essential Hypertension. Journal of Cardiovascular Pharmacology 62:4, pages 388-393.
Crossref
. (2013) European Perspectives. Circulation 127:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.